Scientists showed that Ten-Eleven Translocation-2 (Tet2) deficient mouse hematopoietic stem and progenitor cells undergo malignant transformation upon compromised gene regulation through heterozygous deletion of an upstream regulatory region of the PU.1 gene.
[Blood Cancer Discovery]